Safety and tolerability of adjunctive eslicarbazepine acetate in adolescents with focal-onset seizures: Data from three double-blind, placebo-controlled randomized clinical studies

被引:0
|
作者
Garcia-Penas, Juan-Jose [1 ]
Ikedo, Fabio [2 ]
Fonseca, Miguel [2 ]
Fernandez, Guillermo Castilla [2 ]
Pereira, Ana [2 ]
Moreira, Joana [2 ]
Gama, Helena [2 ]
机构
[1] Nino Jesus Pediat Univ Hosp, Epilepsy Unit, Neuropediat Sect, Madrid, Spain
[2] BIAL Portela & Ca SAS Mamede Coronado, Div Res & Dev, Porto, Portugal
关键词
D O I
10.1016/j.jns.2021.119157
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
119157
引用
收藏
页码:159 / 160
页数:2
相关论文
共 50 条
  • [41] Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies of the Safety, Tolerability and Pharmacokinetics of Naldemedine in Healthy Volunteers
    Fukumura, Kazuya
    Yokota, Takaaki
    Baba, Yuko
    Camilo, Juan
    Ferreira, Arjona
    GASTROENTEROLOGY, 2016, 150 (04) : S537 - S538
  • [42] Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies on the Safety, Tolerability, and Pharmacokinetics of Naldemedine in Healthy Volunteers
    Fukumura, Kazuya
    Yokota, Takaaki
    Baba, Yuko
    Ferreira, Juan Camilo Arjona
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (05): : 474 - 483
  • [43] A randomized, double-blind, placebo-controlled trial of aripiprazole in the treatment of adolescents with schizophrenia: A report on tolerability
    Carson, William H.
    Robb, Adelaide S.
    Van-Beek, Alet
    Johnson, Brian
    Mallikaarjun, Suresh
    Ivanova, Svetlana
    Forbes, Robert A.
    Marcus, Ronald N.
    Nyilas, Margaretta
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (06) : 880 - 881
  • [44] Design of a double-blind, randomized, placebo-controlled phase 2 trial of Darigabat as adjunctive therapy in adults with drug-resistant focal onset seizures (REALIZE)
    Dandurand, A.
    French, J.
    Gurrell, R.
    Chang, I.
    Frohlich, L.
    Ang, K.
    Versavel, S.
    Pfister, S.
    Perry, P.
    Leoni, M.
    Sanchez, R.
    EPILEPSIA, 2023, 64 : 309 - 310
  • [45] Safety, Tolerability, and Pharmacokinetics of β-Cryptoxanthin Supplementation in Healthy Women: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
    Tan, Karen M. L.
    Chee, Jolene
    Lim, Kezlyn L. M.
    Ng, Maisie
    Gong, Min
    Xu, Jia
    Tin, Felicia
    Natarajan, Padmapriya
    Lee, Bee Lan
    Ong, Choon Nam
    Tint, Mya Thway
    Kee, Michelle Z. L.
    Muller-Riemenschneider, Falk
    Gluckman, Peter D.
    Meaney, Michael J.
    Kumar, Mukkesh
    Karnani, Neerja
    Eriksson, Johan G.
    Nandanan, Bindu
    Wyss, Adrian
    Cameron-Smith, David
    NUTRIENTS, 2023, 15 (10)
  • [46] BRIVARACETAM AS ADJUNCTIVE TREATMENT OF REFRACTORY PARTIAL-ONSET SEIZURES IN ADULTS: RESULTS FROM TWO RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALS
    Biton, V.
    Werhahn, K. J.
    Johnson, M. E.
    Falter, U.
    Climo, K.
    Schelstraete, I.
    Brodsky, A. C.
    von Rosenstiel, P.
    EPILEPSIA, 2009, 50 : 106 - 107
  • [47] A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF GANAXOLONE AS ADD-ON THERAPY IN ADULTS WITH UNCONTROLLED PARTIAL ONSET SEIZURES
    Tsai, Julia
    Pennell, P. B.
    Garofalo, E.
    EPILEPSIA, 2009, 50 : 100 - 100
  • [48] Safety and tolerability of Ganoderma lucidum in healthy subjects:: A double-blind randomized placebo-controlled trial
    Wicks, Sheila M.
    Tong, Robin
    Wang, Chong-Zhi
    O'Connor, Michael
    Karrison, Theodore
    Li, Shang
    Moss, Jonathan
    Yuan, Chun-Su
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2007, 35 (03): : 407 - 414
  • [49] Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study
    French, Jacqueline A.
    Lawson, John A.
    Yapici, Zuhal
    Ikeda, Hiroko
    Polster, Tilman
    Nobbout, Rima
    Curatolo, Paolo
    de Vries, Petrus J.
    Diugos, Dennis J.
    Berkowitz, Noah
    Voi, Maurizio
    Peyrard, Severine
    Pelov, Diana
    Franz, David N.
    LANCET, 2016, 388 (10056): : 2153 - 2163
  • [50] ADJUNCTIVE BRIVARACETAM IN ADULTS WITH UNCONTROLLED FOCAL EPILEPSY: RESULTS FROM TWO RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALS
    Werhahn, K. J.
    Biton, V
    Johnson, M. E.
    Merschhemke, M.
    Lu, S.
    EPILEPSIA, 2010, 51 : 150 - 150